三里宾的信号效应,组合和临床应用
1Division of Laboratory Medicine, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
一种核酸酶的三氨酸 (TCN) 抑制了DNA合成,并准了Akt. 组合显示了对各种癌症和肺部损伤的承诺,包括COVID-19的那些.
科学领域:
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 三氨酸 (TCN) 是一种三环核酸化合物,于1971年合成.
- TCN抑制了DNA合成,并表现出Akt的选择性.
- 单剂量TCN在固体瘤中具有有限的临床活性.
研究的目的:
- 审查TCN在各种恶性瘤的联合治疗中的疗效.
- 探索TCN在治疗非癌症疾病 (如肺部损伤) 的潜力.
主要方法:
- 涉及TCN的临床前和临床研究的文献综述.
- 对TCN的Akt抑制机制的分析.
- 评估与TCN和其他药物的组合疗法.
主要成果:
- 临床前研究表明,TCN组合对胰腺,乳腺,前列腺癌,胰岛素瘤,肠道神经内分泌瘤和肝细胞癌有效.
- 通过Akt抑制,TCN显示了治疗肺部损伤的潜力,包括与COVID-19相关的肺部损伤.
结论:
- TCN组合疗法为治疗各种恶性瘤提供了一个有希望的策略.
- TCN的Akt抑制为肺损伤和病毒感染提供了治疗途径.
更多相关视频
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
10:24NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases
Published on: June 30, 2019
相关概念视频
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Clinical Trials: Overview
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
